Archive: September 2016
Cirrhosis
Hepatitis E Virus Infection and Cirrhosis of the Liver
Jean-Marie Péron, MD, PhD
G&H How common is hepatitis E virus infection? JMP Throughout the world, there are approximately 20 million hepatitis E virus infections each year. This number […]
Letter From the Editor
Letter From the Editor: Colorectal Cancer
Gastroenterology & Hepatology Volume 12, Issue 9, September 2016 Colorectal cancer is one of the most common types of cancers and causes of cancer deaths in […]
IBD
Vaccinating Patients With Inflammatory Bowel Disease
Jason Reich, MD, Sharmeel Wasan, MD, and Francis A. Farraye, MD, MSc
Abstract: Patients with inflammatory bowel disease (IBD) are not vaccinated at the same rate as general medical patients. IBD places patients at increased risk for […]
Colorectal Cancer
Colorectal Cancer Screening Navigation for the Underserved: Experience of an Urban Program
Alicia Lamanna, MHA, Heather Sheaffer, DSW, LCSW, Carmen Guerra, MD, MSCE, FACP, and Michael Kochman, MD, AGAF, FASGE
Abstract: Colorectal cancer is the third leading cause of cancer deaths in the United States. Although colorectal cancer screenings are effective and recommended by all clinical […]
Endoscopy
Treating Eosinophilic Esophagitis in Patients With a Narrow-Caliber Esophagus
Evan S. Dellon, MD, MPH
G&H How do the signs and symptoms of eosinophilic esophagitis differ between a patient with a regular-caliber esophagus compared with a narrow-caliber esophagus? ED The […]
IBD
Update on Tofacitinib for Inflammatory Bowel Disease
Gastroenterology & Hepatology Volume 12, Issue 9, September 2016 Brian Feagan, MD Professor Department of Medicine University of Western Ontario Robarts Clinical Trials Robarts Research Institute […]
GERD
Radiofrequency Ablation for Dysplastic and Nondysplastic Barrett Esophagus
George Triadafilopoulos, MD
G&H Which ablative therapies are currently being used to treat Barrett esophagus? GT Several modalities are currently being used to treat Barrett esophagus. The leading modality […]